| Financial Year |
March 31 2023 |
| Monetary Funds |
401,875,983.77 |
| Held-for-trading Financial Assets |
492,594,398.90 |
| Notes Receivable |
210,568,985.19 |
| Accounts Receivable |
503,795,140.33 |
| Advances to Suppliers |
18,061,353.34 |
| Other Receivables |
78,481,187.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
385,364,686.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,340,503.92 |
| Other Current Assets |
8,152,447.84 |
| Total Current Assets |
2,110,975,408.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,158,109.49 |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,984,473.65 |
| Fixed Assetes |
344,591,268.38 |
| Under-construction Projects |
250,272,285.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
135,409,909.19 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,544,740.55 |
| Deferred Income Tax Assets |
83,027,518.96 |
| Other Non-Current Assets |
16,775,840.14 |
| Sub-Total of Non-Current Assets |
951,691,130.43 |
| Total Assets |
3,062,666,539.22 |
| Short-Term Loans |
35,296,049.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
135,230,469.28 |
| Accounts Payable |
217,126,542.62 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,904,700.54 |
| Taxes Payable |
24,977,502.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
52,768,283.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,202,203.23 |
| Other Current Liabilities |
181,397,493.33 |
| Sub-Total of Current Liabilities |
812,272,080.69 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,505,308.81 |
| Other Non-Current Liabilities |
89,624.62 |
| Sub-Total of Non-Current Liabilities |
74,629,483.87 |
| Total Liabilities |
886,901,564.56 |
| Paid-In Capital(Or Share Stock) |
279,331,000.00 |
| Capital Surplus |
1,186,610,513.84 |
| Surplus Reserve |
169,029,477.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
540,793,983.17 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,175,764,974.66 |
| Owner's Equity（Stockholder's Equity） |
2,175,764,974.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,062,666,539.22 |
